Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 7 | 2023 | 230 | 2.000 |
Why?
|
| Community Health Workers | 3 | 2023 | 26 | 1.320 |
Why?
|
| Tobacco Use Cessation | 2 | 2023 | 7 | 1.100 |
Why?
|
| Tobacco Use | 2 | 2023 | 24 | 1.050 |
Why?
|
| Advance Care Planning | 1 | 2023 | 43 | 0.860 |
Why?
|
| Tobacco Products | 1 | 2023 | 41 | 0.860 |
Why?
|
| Vegetables | 1 | 2022 | 45 | 0.820 |
Why?
|
| Pediatric Obesity | 1 | 2022 | 22 | 0.820 |
Why?
|
| Cigarette Smoking | 2 | 2019 | 30 | 0.790 |
Why?
|
| Weight Gain | 1 | 2018 | 123 | 0.590 |
Why?
|
| Smoking | 3 | 2020 | 609 | 0.490 |
Why?
|
| Culturally Competent Care | 2 | 2018 | 12 | 0.420 |
Why?
|
| Tobacco Use Disorder | 2 | 2020 | 108 | 0.410 |
Why?
|
| Mood Disorders | 2 | 2012 | 81 | 0.380 |
Why?
|
| Interferon-alpha | 2 | 2012 | 234 | 0.370 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 2903 | 0.340 |
Why?
|
| Counseling | 2 | 2019 | 145 | 0.310 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 865 | 0.290 |
Why?
|
| Depression | 2 | 2014 | 473 | 0.270 |
Why?
|
| Humans | 19 | 2023 | 86678 | 0.250 |
Why?
|
| Health Promotion | 1 | 2015 | 160 | 0.230 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 204 | 0.220 |
Why?
|
| Resilience, Psychological | 1 | 2022 | 23 | 0.220 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 157 | 0.220 |
Why?
|
| Melanoma | 2 | 2013 | 459 | 0.210 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2012 | 19 | 0.210 |
Why?
|
| Paroxetine | 1 | 2012 | 26 | 0.210 |
Why?
|
| Trust | 1 | 2023 | 95 | 0.210 |
Why?
|
| Community Health Services | 1 | 2023 | 80 | 0.210 |
Why?
|
| Metabolic Syndrome | 1 | 2023 | 142 | 0.200 |
Why?
|
| Social Support | 1 | 2013 | 193 | 0.200 |
Why?
|
| Catatonia | 1 | 2011 | 8 | 0.200 |
Why?
|
| Fruit | 1 | 2022 | 75 | 0.200 |
Why?
|
| Affect | 1 | 2013 | 386 | 0.190 |
Why?
|
| Menthol | 1 | 2020 | 3 | 0.190 |
Why?
|
| Illinois | 1 | 2022 | 462 | 0.190 |
Why?
|
| Behavioral Symptoms | 1 | 2009 | 15 | 0.180 |
Why?
|
| Blood Glucose | 1 | 2014 | 873 | 0.180 |
Why?
|
| Primary Health Care | 1 | 2023 | 339 | 0.180 |
Why?
|
| Adult | 11 | 2023 | 25659 | 0.180 |
Why?
|
| Feeding Behavior | 1 | 2022 | 324 | 0.170 |
Why?
|
| Hotlines | 1 | 2018 | 3 | 0.170 |
Why?
|
| Female | 11 | 2023 | 44550 | 0.160 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 222 | 0.160 |
Why?
|
| Smoking Prevention | 1 | 2018 | 43 | 0.160 |
Why?
|
| Health Behavior | 1 | 2019 | 183 | 0.160 |
Why?
|
| Multilevel Analysis | 1 | 2018 | 21 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2023 | 508 | 0.160 |
Why?
|
| Citalopram | 2 | 2013 | 20 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2012 | 512 | 0.160 |
Why?
|
| Middle Aged | 9 | 2019 | 25040 | 0.150 |
Why?
|
| Overweight | 1 | 2018 | 118 | 0.150 |
Why?
|
| Chicago | 1 | 2022 | 1380 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 426 | 0.150 |
Why?
|
| Child | 3 | 2023 | 6928 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 827 | 0.140 |
Why?
|
| Cognition | 1 | 2020 | 571 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1375 | 0.120 |
Why?
|
| Male | 9 | 2019 | 40988 | 0.120 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2013 | 131 | 0.110 |
Why?
|
| Adolescent | 5 | 2023 | 8984 | 0.110 |
Why?
|
| Interleukin-2 | 1 | 2013 | 249 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2023 | 8496 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2013 | 256 | 0.100 |
Why?
|
| Hydrocortisone | 1 | 2013 | 298 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 3642 | 0.100 |
Why?
|
| Young Adult | 4 | 2022 | 5980 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2013 | 1824 | 0.090 |
Why?
|
| Risk Factors | 3 | 2023 | 5420 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2018 | 7998 | 0.080 |
Why?
|
| Neoplasms | 1 | 2022 | 2898 | 0.080 |
Why?
|
| Aged | 5 | 2018 | 18423 | 0.070 |
Why?
|
| Multilingualism | 1 | 2015 | 10 | 0.070 |
Why?
|
| Fasting | 1 | 2014 | 161 | 0.060 |
Why?
|
| Demography | 1 | 2013 | 177 | 0.060 |
Why?
|
| Income | 1 | 2013 | 76 | 0.060 |
Why?
|
| Self Care | 1 | 2014 | 164 | 0.050 |
Why?
|
| Urban Population | 1 | 2014 | 214 | 0.050 |
Why?
|
| Perception | 1 | 2013 | 168 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2013 | 220 | 0.050 |
Why?
|
| Ribavirin | 1 | 2012 | 58 | 0.050 |
Why?
|
| Lorazepam | 1 | 2011 | 16 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2011 | 295 | 0.050 |
Why?
|
| Antipruritics | 1 | 2020 | 2 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1019 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 123 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 487 | 0.050 |
Why?
|
| Methylphenidate | 1 | 2009 | 10 | 0.040 |
Why?
|
| Serotonin Antagonists | 1 | 2009 | 35 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2023 | 770 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 117 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2012 | 210 | 0.040 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2009 | 44 | 0.040 |
Why?
|
| Public Health | 1 | 2020 | 129 | 0.040 |
Why?
|
| Syndrome | 1 | 2009 | 446 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 916 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2011 | 484 | 0.040 |
Why?
|
| Obesity | 1 | 2023 | 964 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1961 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 1056 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6513 | 0.030 |
Why?
|
| Time Factors | 1 | 2012 | 5214 | 0.030 |
Why?
|
| United States | 1 | 2015 | 6681 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 106 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2013 | 129 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 895 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 2360 | 0.010 |
Why?
|